October 11, 2017 | Today’s News
Today's Top Story Landscape may be shifting on off-label promotion. An article in The Washington Post outlines efforts to lift restrictions on off-label marketing of pharmaceuticals. The writer notes that the state of Arizona recently enacted a law allowing manufacturers to share with providers certain information regarding off-label uses of drugs and medical devices, and in two recent court cases, federal district courts ruled that the First Amendment does not allow the U.S. Food and Drug Administration (FDA) [...]